Skip to search formSkip to main contentSkip to account menu

5-hydroxymethyl tolterodine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The muscarinic receptors have been used as target in treatment of overactive bladder (OAB) for a long time. These patients have… 
2016
2016
Hypothesis / aims of study Muscarinic receptor antagonists and β3 adrenoceptor agonist are the currently recommended medicines… 
2016
2016
Hypothesis / aims of study Fesoterodine (4 or 8 mg once daily (QD)), an antimuscarinic (1), and mirabegron (25 or 50 mg QD), a β3… 
2016
2016
Hypothesis / aims of study Medicines with different mode of actions (MOA) such as antimuscarinics and β3 agonist, are available… 
2014
2014
  • 2014
  • Corpus ID: 34718327
Hypothesis / aims of study Fesoterodine is a relatively novel antimuscarinic agent for the treatment of overactive bladder (OAB… 
2013
2013
Hypothesis / aims of study The urothelium is important to manifest the OAB symptoms in BOO and the expression changes of various… 
2011
2011
Hypothesis / aims of study Pre-clinical studies in anesthetized dogs suggest that the active metabolite of fesoterodine (5… 
2007
2007
Hypothesis / aims of study Although clinical studies suggest that many patients with overactive bladder (OAB) who are…